A Pragmatist’s View on Biomarker-Driven Decisions in Oncology: Episode 2
Website: https://www.onclive.comTwitter: https://twitter.com/OncLiveFacebook: https://www.facebook.com/OncLive/LinkedIn: https://www.linkedin.com/company/onc…
Website: https://www.onclive.comTwitter: https://twitter.com/OncLiveFacebook: https://www.facebook.com/OncLive/LinkedIn: https://www.linkedin.com/company/onc…
Renier Brentjens, MD, PhD, discusses the current landscape of CAR T-cell therapy and ongoing efforts to expand its application beyond B-cell malignancies.
In this TV interview, recorded 1/22/25, I discuss why it’s important to track the mutations in avian influenza viruses that infect humans and the value…
Nivolumab plus ipilimumab–based treatment regimens have shown long-term, durable efficacy benefits in patients with metastatic NSCLC. Here we report clinical outcomes from a pooled analysis…
Drs Camidge and Boire discuss Dr Boire’s path to becoming a physician-scientist and how cellular biology research can improve outcomes for patients with cancer.
An abstract is unavailable.
Presented by the AHNS Reconstructive Head & Neck Surgery Section Moderator: Chad Zender, MD, Professor Otolaryngology, Director Head and Neck Surgery, University Of Cincinnati AHNS…
Tanios S. Bekaii-Saab, MD, and Yelena Y. Janjigian, MD, preview top presentations from this year’s Gastrointestinal Cancers Symposium.
During our combined 35 years working to advance diagnostic capabilities for cancer—as a pathologist and as a bioinformatician, respectively—we’ve had the opportunity to help build…
A pulmonary embolism is when a blood clot blocks a blood vessel in your lungs. It can be life-threatening if not treated quickly.In this episode…
OST-HER2 led to significant 12-month event-free survival and demonstrated favorable overall survival trends at 1 and 2 years in recurrent, fully resected osteosarcoma and lung…